triphenyltetrazolium has been researched along with s6c sarafotoxin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crockett, TR; Gray, GA; Kane, KA; Wainwright, CL | 1 |
1 other study(ies) available for triphenyltetrazolium and s6c sarafotoxin
Article | Year |
---|---|
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats.
Topics: Animals; Blood Pressure; Coronary Disease; Disease Models, Animal; Drug Administration Schedule; Evans Blue; Glyceraldehyde-3-Phosphate Dehydrogenases; Injections, Intravenous; Ligation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Time Factors; Ventricular Fibrillation; Viper Venoms | 2004 |